Silibinin modulates the NF-κb pathway and pro-inflammatory cytokine production by mononuclear cells from preeclamptic women

Journal of Reproductive Immunology

Volumn 95, Issue 1-2, 2012, Pages 67-72

  Giorgi, Vanessa S Innocenti ^a   Peracoli, Maria Terezinha S ^a   Peracoli, José C ^a   Witkin, Steven S ^a,b   Bannwart Castro, Camila F ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

IL 1 ; NF B; Preeclampsia; Silibinin; TNF

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; SILIBININ; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; FEMALE; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PREECLAMPSIA; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; DOWN-REGULATION; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; NF-KAPPA B; PRE-ECLAMPSIA; PREGNANCY; SILYMARIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84865564697     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2012.06.004     Document Type: Article

References (30)

1. Bannwart C.F., Nakaira-Takahagi E., Golim M.A., de Medeiros L.T., Romão M., Weel I.C., et al. Downregulation of nuclear factor-kappa B (NF-kappaB) pathway by silibinin in human monocytes challenged with Paracoccidioides brasiliensis. Life Sci. 2010, 86:880-886.
2. Bannwart C.F., Peraçoli J.C., Nakaira-Takahagi E., Peraçoli M.T.S. Inhibitory effect of silibinin on tumor necrosis factor-alpha and hydrogen peroxide production by human monocytes. Nat. Prod. Res. 2010, 24:1747-1757.
3. Beckmann I., Efraim S.B., Vervoort M., Visser W., Wallenburg H.C. Tumor necrosis factor-alpha in whole blood cultures of preeclamptic patients and healthy pregnant and nonpregnant women. Hypertens. Pregnancy 2004, 23:319-329.
4. Borzychowski A.M., Sargen T.I.L., Redman C.W. Inflammation and pre-eclampsia. Semin. Fetal Neonatal Med. 2006, 11:309-316.
5. Chen C.C., Rosenbloom C.L., Anderson D.C., Manning A.M. Selective inhibition of E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 expression by inhibitors of I kappa B-alpha phosphorylation. J. Immunol. 1995, 155:3538-3545.
6. Dekker G.A., Sibai B.M. Etiology and pathogenesis of preeclampsia. Current concepts. Am. J. Obstet. Gynecol. 1998, 179:1359-1375.
7. Dixit N., Baboota S., Kohli K., Ahmad S., Ali J. Silymarin: a review of pharmacological aspects and bioavailability enhancement approaches. Indian J. Pharmacol. 2007, 39:172-179.
8. Eurich D., Bahra M., Berg T., Boas-Knoop S., Biermer M., Neuhaus R., et al. Treatment of hepatitis C-virus-reinfection after liver transplant with silibinin in nonresponders to pegylated interferon-based therapy. Exp. Clin. Transplant. 2011, 9:1-6.
9. Ferenci P., Scherzer T.M., Kerschner H., Rutter K., Beinhardt S., Hofer H., et al. Silibinin is a potent antiviral agent in patients with chronic hepatitis C not responding to pegylated interferon/ribavirin therapy. Gastroenterology 2008, 135:1561-1567.
10. Jonsson Y., Ruber M., Matthiesen L., Berg G., Nieminen K., Sharma S., et al. Cytokine mapping of sera from women with preeclampsia and normal pregnancies. J. Reprod. Immunol. 2006, 70:83-91.
11. Kalinderis M., Papanikolaou A., Kalinderi K., Ioannidou E., Giannoulis C., Karagiannis V., et al. Elevated serum levels of interleukin-6, interleukin-1β and human chorionic gonadotropin in pre-eclampsia. Am. J. Reprod. Immunol. 2011, 66:468-475.
12. Lin W.W., Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Invest. 2007, 117:1175-1183.
13. Lok C.A., Jebbink J., Nieuwland R., Faas M.M., Boer K., Sturk A., et al. Leukocyte activation and circulating leukocyte-derived microparticles in preeclampsia. Am. J. Reprod. Immunol. 2009, 61:346-359.
14. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin-Phenol reagent. J. Biol. Chem. 1951, 193:265-275.
15. Luppi P., Tse H., Lain K.Y., Markovic N., Piganelli J.D., DeLoia J.A. Preeclampsia activates circulating immune cells with engagement of the NF-kappaB pathway. Am. J. Reprod. Immunol. 2006, 56:135-144.
16. Maeda S., Hsu L.C., Liu H., Bankston L.A., Iimura M., Kagnoff M.F., Eckmann L., Karin M. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science 2005, 307:734-738.
17. Manna S.K., Mukhopadhyay A., Van N.T., Aggarwal B.B. Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis. J. Immunol. 1999, 163:6800-6809.
18. Matsusaka T., Fujikawa K., Nishio Y., Mukaida N., Matsushima K., Kishimoto T., et al. Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:10193-10197.
19. McCracken S.A., Drury C.L., Lee H.S., Morris J.M. Pregnancy is associated with suppression of the nuclear factor kappaB/IkappaB activation pathway in peripheral blood mononuclear cells. J. Reprod. Immunol. 2003, 58:27-47.
20. Peraçoli J.C., Rudge M.V., Peraçoli M.T. Tumor necrosis factor-alpha in gestation and puerperium of women with gestational hypertension and pre-eclampsia. Am. J. Reprod. Immunol. 2007, 57:177-185.
21. Peraçoli M.T., Bannwart C.F., Cristofalo R., Borges V.T., Costa R.A.A., Peraçoli J.C. Increased reactive oxygen species and tumor necrosis factor-alpha production by monocytes are associated with elevated levels of uric acid in pre-eclamptic women. Am. J. Reprod. Immunol. 2011, 66:460-467.
22. Polyak S.J., Morishima C., Lohmann V., Pal S., Lee D.Y., Liu Y., et al. Identification of hepatoprotective flavonolignans from silymarin. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:5995-5999.
23. Pradhan S.C., Girish C. Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. Indian J. Med. Res. 2006, 124:491-504.
24. Redman C.W., Sargent I.L. Preeclampsia and the systemic inflammatory response. Semin. Nephrol. 2004, 24:565-570.
25. Redman C.W., Sacks G.P., Sargent I.L. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am. J. Obstet. Gynecol. 1999, 180:499-506.
26. Saito S., Sakai M. Th1/Th2 balance in preeclampsia. J. Reprod. Immunol. 2003, 59:161-173.
27. Singh R.P., Dhanalakshmi S., Tyagi A.K. Dietary feeding of silibinin inhibits advance human prostate carcinoma growth in athymic nude mice and increases plasma insulin-like growth factor binding-protein-3 levels. Cancer Res. 2002, 62:3063-3069.
28. Striz I., Brabcova E., Kolesar L., Liu X.D., Brabcova I., Sekerkova A., et al. Epithelial cells modulate genes associated with NF kappa B activation in co-cultured human macrophages. Immunobiology 2011, 216:1110-1116.
29. Unal E.R., Robinson C.J., Johnson D.D., Chang E.Y. Second-trimester angiogenic factors as biomarkers for future-onset preeclampsia. Am. J. Obstet. Gynecol. 2007, 197. 211.e1-211.e4.
30. Walker J.J. Pre-eclampsia. Lancet 2000, 356:1260-1265.